Followers | 507 |
Posts | 10138 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Thursday, December 17, 2015 11:48:12 AM
bullish 11.4462
resistance breakout
bullish divergence
## source: finance.yahoo.com
Thu, 17 Dec 2015 14:30:02 GMT ~ The Zacks Analyst Blog Highlights: Amgen, ARIAD, Clovis Oncology, Regeneron and Akebia Therapeutics
read full: http://finance.yahoo.com/news/zacks-analyst-blog-highlights-amgen-143002053.html
*********************************************************
Wed, 16 Dec 2015 19:58:07 GMT ~ Biotech Stock Roundup: Amgen Hikes First Quarter Dividend, ARIAD Lowers Iclusig Outlook
read full: http://finance.yahoo.com/news/biotech-stock-roundup-amgen-hikes-195807207.html
*********************************************************
Wed, 16 Dec 2015 13:15:01 GMT ~ Akebia Therapeutics (AKBA) in Focus: Stock Moves Up 13%
read full: http://finance.yahoo.com/news/akebia-therapeutics-akba-focus-stock-131501842.html
*********************************************************
Tue, 15 Dec 2015 21:35:09 GMT ~ Akebia Up on Mitsubishi Tanabe Pharma Deal for Vadadustat
read full: http://finance.yahoo.com/news/akebia-mitsubishi-tanabe-pharma-deal-213509327.html
*********************************************************
Tue, 15 Dec 2015 13:52:00 GMT ~ 8 Stocks Spiking on Unusually High Volume
read full: http://www.thestreet.com/story/13397739/1/8-stocks-spiking-on-unusually-high-volume.html?puc=yahoo&cm_ven=YAHOO
*********************************************************
$AKBA charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$AKBA company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/AKBA/company-info
Ticker: $AKBA
OTC Market Place: Not Available
CIK code: not found
Company name: Akebia Therapeutics, Inc.
Incorporated In:
$AKBA share structure
## source: otcmarkets.com
Market Value: Not Available
Shares Outstanding: Not Available
Float: Not Available
Authorized Shares: Not Available
Par Value: Not Available
$AKBA extra dd links
Company name: Akebia Therapeutics, Inc.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/AKBA/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/AKBA/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=AKBA+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=AKBA+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=AKBA+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/AKBA/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/AKBA/news - http://finance.yahoo.com/q/h?s=AKBA+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/AKBA/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/AKBA/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/AKBA/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/AKBA/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/AKBA/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/AKBA/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/AKBA/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/AKBA/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=AKBA+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/AKBA
DTCC (dtcc.com): http://search2.dtcc.com/?q=Akebia+Therapeutics%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Akebia+Therapeutics%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Akebia+Therapeutics%2C+Inc.&x=0&y=0
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/AKBA/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/AKBA
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/AKBA/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/AKBA/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/AKBA/sec-filings
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/AKBA/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/AKBA/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/AKBA/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/AKBA/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=AKBA&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=AKBA
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/AKBA/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=AKBA+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=AKBA+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=AKBA
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=AKBA
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=AKBA+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/AKBA/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=AKBA+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/AKBA.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=AKBA
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/AKBA/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/AKBA/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/AKBA/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/AKBA/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/AKBA
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/AKBA
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/AKBA:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=AKBA
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=AKBA
$AKBA DD Notes ~ http://www.ddnotesmaker.com/AKBA
Recent AKBA News
- Akebia Therapeutics to Report First Quarter 2024 Financial Results and Discuss Recent Business Highlights • PR Newswire (US) • 05/02/2024 12:30:00 PM
- Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • PR Newswire (US) • 05/01/2024 08:05:00 PM
- Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • PR Newswire (US) • 04/02/2024 08:05:00 PM
- Akebia Receives FDA Approval of Vafseo® (vadadustat) Tablets for the Treatment of Anemia due to Chronic Kidney Disease in Adult Patients on Dialysis • PR Newswire (US) • 03/28/2024 12:26:00 AM
- Akebia Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights • PR Newswire (US) • 03/14/2024 08:15:00 PM
- Akebia Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results • PR Newswire (US) • 03/11/2024 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2024 10:49:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2024 10:48:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2024 10:47:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2024 10:46:51 PM
- Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • PR Newswire (US) • 03/01/2024 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 11:03:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 11:02:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 11:01:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 11:00:49 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/29/2024 09:32:13 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/29/2024 09:28:33 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/29/2024 09:27:09 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/27/2024 11:19:02 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/27/2024 11:14:27 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/27/2024 11:11:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:11:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:11:44 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM